當(dāng)前位置：首頁 SCI期刊 SCIE期刊醫(yī)學(xué) 中科院4區(qū) JCRQ2 期刊介紹(非官網(wǎng))

Pharmaceutical Development And TechnologySCIE

國際簡稱：PHARM DEV TECHNOL 參考譯名：藥物開發(fā)與技術(shù)

中科院分區(qū)
4區(qū)
CiteScore分區(qū)
Q2
JCR分區(qū)
Q2

基本信息：: ISSN：1083-7450; E-ISSN：1097-9867; 是否OA：未開放; 是否預(yù)警：否; TOP期刊：否

出版信息：: 出版地區(qū)：UNITED STATES; 出版商：Informa Healthcare; 出版語言：English; 出版周期：Bimonthly; 出版年份：1996; 研究方向：醫(yī)學(xué)-藥學(xué)

評價信息：: 影響因子：2.6; H-index：50; CiteScore指數(shù)：5.9; SJR指數(shù)：0.476; SNIP指數(shù)：0.609

發(fā)文數(shù)據(jù)：: Gold OA文章占比：5.68%; 研究類文章占比：84.52%; 年發(fā)文量：84; 自引率：0.0294...; 開源占比：0.024; 出版撤稿占比：0; 出版國人文章占比：0.11; OA被引用占比：0.0074...

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問題

英文簡介Pharmaceutical Development And Technology期刊介紹

Pharmaceutical Development & Technology publishes research on the design, development, manufacture, and evaluation of conventional and novel drug delivery systems, emphasizing practical solutions and applications to theoretical and research-based problems. The journal aims to publish significant, innovative and original research to advance the frontiers of pharmaceutical development and technology.

Through original articles, reviews (where prior discussion with the EIC is encouraged), short reports, book reviews and technical notes, Pharmaceutical Development & Technology covers aspects such as:

-Preformulation and pharmaceutical formulation studies

-Pharmaceutical materials selection and characterization

-Pharmaceutical process development, engineering, scale-up and industrialisation, and process validation

-QbD in the form a risk assessment and DoE driven approaches

-Design of dosage forms and drug delivery systems

-Emerging pharmaceutical formulation and drug delivery technologies with a focus on personalised therapies

-Drug delivery systems research and quality improvement

-Pharmaceutical regulatory affairs

This journal will not consider for publication manuscripts focusing purely on clinical evaluations, botanicals, or animal models.

期刊簡介Pharmaceutical Development And Technology期刊介紹

《Pharmaceutical Development And Technology》自1996出版以來，是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個領(lǐng)域的原創(chuàng)研究提供一個展示平臺，以促進(jìn)醫(yī)學(xué)領(lǐng)域的的進(jìn)步。該刊鼓勵先進(jìn)的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見解，或?qū)彶槎嗄陙砟硞€重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時報道醫(yī)學(xué)領(lǐng)域的最新進(jìn)展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點：

預(yù)計審稿時間：約1.0個月
醫(yī)學(xué)
PHARMACOLOGY & PHARMACY
SCIE
中科院4區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）Pharmaceutical Development And Technology Cite Score數(shù)據(jù)

CiteScore：5.9
SJR：0.476
SNIP：0.609

學(xué)科類別	分區(qū)	排名	百分位
大類：Pharmacology, Toxicology and Pharmaceutics 小類：Pharmaceutical Science	Q2	59 / 183	68%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻(xiàn)計量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫中收集的引文為基礎(chǔ)，針對的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標(biāo)來評價。

歷年Cite Score趨勢圖

中科院SCI分區(qū)Pharmaceutical Development And Technology 中科院分區(qū)

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)
醫(yī)學(xué)	4區(qū)	PHARMACOLOGY & PHARMACY 藥學(xué)	4區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運(yùn)用科學(xué)計量學(xué)方法對國際、國內(nèi)學(xué)術(shù)期刊依據(jù)影響力進(jìn)行等級劃分的期刊評價標(biāo)準(zhǔn)。它為我國科研、教育機(jī)構(gòu)的管理人員、科研工作者提供了一份評價國際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國各地高校、科研機(jī)構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個層次，類似于“優(yōu)、良、及格”等。最開始，這個分區(qū)只是為了方便圖書管理及圖書情報領(lǐng)域的研究和期刊評估。之后中科院分區(qū)逐步發(fā)展成為了一種評價學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢圖

JCR分區(qū)Pharmaceutical Development And Technology JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：PHARMACOLOGY & PHARMACY	SCIE	Q2	173 / 354	51.3%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：PHARMACOLOGY & PHARMACY	SCIE	Q2	122 / 354	65.68%

JCR分區(qū)的優(yōu)勢在于它可以幫助讀者對學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評估。不同學(xué)科的文章引用量可能存在較大的差異，此時單獨(dú)依靠影響因子(IF)評價期刊的質(zhì)量可能是存在一定問題的。因此，JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發(fā)文數(shù)據(jù)

2023-2024 年國家/地區(qū)發(fā)文量統(tǒng)計

國家/地區(qū)數(shù)量
CHINA MAINLAND63
USA49
Egypt39
Iran39
Brazil26
England26
Turkey26
India23
GERMANY (FED REP GER)20
New Zealand19

本刊中國學(xué)者近年發(fā)表論文

1、Bilayer nanofibrous wound dressing prepared by electrospinning containing gallic acid and quercetin with improved biocompatibility, antibacterial, and antioxidant effects
Author: Lv, Yuanju; Wu, Wenli; Liu, Zemei; Zheng, Guangyan; Wang, Lihong; Che, Xin

Journal: PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY. 2023; Vol. 28, Issue 1, pp. 18-29. DOI: 10.1080/10837450.2022.2160734
2、Microemulsion-thermosensitive gel composites as in situ-forming drug reservoir for periodontitis tissue repair through alveolar bone and collagen regeneration strategy
Author: Ding, Yang; Wang, Yuxiao; Li, Jiaxin; Tang, Maomao; Chen, Hairong; Wang, Guichun; Guo, Jian; Gui, Shuangying

Journal: PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY. 2023; Vol. 28, Issue 1, pp. 30-39. DOI: 10.1080/10837450.2022.2161574
3、Bacterial outer membrane vesicles-cloaked modified zein nanoparticles for oral delivery of paclitaxel
Author: Wang, Zeyu; Chu, Yuqi; Tao, Xu; Li, Jianchao; Wang, Lihong; Sang, Yuli; Lu, Xiuli; Chen, Lijiang

Journal: PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1080/10837450.2023.2204163
4、Fabrication and in vitro characterization of zinc oxide nanoparticles and hyaluronic acid-containing carboxymethylcellulose gel for wound healing application
Author: Paramadini, Adanti Wido; Chinavinijkul, Panarin; Meemai, Aniroot; Thongkam, Peerawat; Apasuthirat, Adisorn; Nasongkla, Norased

Journal: PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY. 2023; Vol. 28, Issue 1, pp. 95-108. DOI: 10.1080/10837450.2022.2164304
5、Surface Modification of lactose carrier particles using a fluid bed coater to improve fine particle fraction for dry powder inhalers
Author: Gong, Qin Qin; Tay, Justin Yong Soon; Veronica, Natalia; Xu, Jian; Heng, Paul Wan Sia; Zhang, Yong Ping; Liew, Celine Valeria

Journal: PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY. 2023; Vol. 28, Issue 2, pp. 164-175. DOI: 10.1080/10837450.2023.2171434
6、Preparation and cytotoxicity evaluation of folic acid-modified YF8-OA self-assembled lipid prodrug nanoparticles
Author: Li, Fu; Yang, Fangfang; Guan, Chenxi; Wei, Pengcheng; He, Dongqiong; Li, Qingwen; Wang, Lisheng; Yuan, Mingqing

Journal: PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1080/10837450.2023.2206487
7、Application of a novel multicomponent nanoemulsion to tumor therapy Based on the theory of unification of drugs and excipients
Author: Li, Quandong; Chen, Xinru; Lin, Wen; Guo, Xiaofeng; Ma, Yan

Journal: PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1080/10837450.2023.2196330
8、Mucoadhesive buccal film containing ornidazole and dexamethasone for oral ulcers: in vitro and in vivo studies.
Author: Zhang C¹, Liu Y¹, Li W¹, Gao P², Xiang D¹, Ren X¹, Liu D¹.

Journal: Pharm Dev Technol. 2019 Jan;24(1):118-126. doi: 10.1080/10837450.2018.1428814. Epub 2018 Jan 25.